Literature DB >> 11280628

Selenium and the "free" electron. Selenium--a trace to be followed in septic or inflammatory ICU patients?

X Forceville.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11280628     DOI: 10.1007/s001340000779

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  18 in total

1.  Selenium compounds have disparate abilities to impose oxidative stress and induce apoptosis.

Authors:  M S Stewart; J E Spallholz; K H Neldner; B C Pence
Journal:  Free Radic Biol Med       Date:  1999-01       Impact factor: 7.376

2.  Selenium replacement in patients with severe systemic inflammatory response syndrome improves clinical outcome.

Authors:  M W Angstwurm; J Schottdorf; J Schopohl; R Gaertner
Journal:  Crit Care Med       Date:  1999-09       Impact factor: 7.598

3.  Inhibition of NF-kappaB DNA binding and nitric oxide induction in human T cells and lung adenocarcinoma cells by selenite treatment.

Authors:  I Y Kim; T C Stadtman
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-25       Impact factor: 11.205

4.  Defining the role of oxyradicals in the pathogenesis of sepsis.

Authors:  J J Zimmerman
Journal:  Crit Care Med       Date:  1995-04       Impact factor: 7.598

Review 5.  The essential trace elements.

Authors:  W Mertz
Journal:  Science       Date:  1981-09-18       Impact factor: 47.728

Review 6.  Orphan selenoproteins.

Authors:  R F Burk; K E Hill
Journal:  Bioessays       Date:  1999-03       Impact factor: 4.345

Review 7.  Human disease, free radicals, and the oxidant/antioxidant balance.

Authors:  J M McCord
Journal:  Clin Biochem       Date:  1993-10       Impact factor: 3.281

8.  Relations between the selenium status and the low T3 syndrome after major trauma.

Authors:  M M Berger; T Lemarchand-Béraud; C Cavadini; R Chioléro
Journal:  Intensive Care Med       Date:  1996-06       Impact factor: 17.440

9.  Selenium-mediated inhibition of transcription factor NF-kappa B and HIV-1 LTR promoter activity.

Authors:  V Makropoulos; T Brüning; K Schulze-Osthoff
Journal:  Arch Toxicol       Date:  1996       Impact factor: 5.153

10.  The interactions between selenium and iodine deficiencies in man and animals.

Authors:  J R Arthur; G J Beckett; J H Mitchell
Journal:  Nutr Res Rev       Date:  1999-06       Impact factor: 7.800

View more
  6 in total

1.  Serum selenium and glutathione peroxidase-3 activity: biomarkers of systemic inflammation in the critically ill?

Authors:  William Manzanares; Alberto Biestro; Federico Galusso; Maria H Torre; Nelly Mañay; Gustavo Pittini; Gianella Facchin; Gil Hardy
Journal:  Intensive Care Med       Date:  2008-11-26       Impact factor: 17.440

2.  Seleno-enzymes and seleno-compounds: the two faces of selenium.

Authors:  Xavier Forceville
Journal:  Crit Care       Date:  2006       Impact factor: 9.097

Review 3.  Selenium deficiency and the effects of supplementation on preterm infants.

Authors:  Renata Germano B O N Freitas; Roberto Jose N Nogueira; Maria Angela R G M Antonio; Antonio de Azevedo Barros-Filho; Gabriel Hessel
Journal:  Rev Paul Pediatr       Date:  2014-03

4.  Effects of high doses of selenium, as sodium selenite, in septic shock: a placebo-controlled, randomized, double-blind, phase II study.

Authors:  Xavier Forceville; Bruno Laviolle; Djillali Annane; Dominique Vitoux; Gérard Bleichner; Jean-Michel Korach; Emmanuel Cantais; Hugues Georges; Jean-Louis Soubirou; Alain Combes; Eric Bellissant
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

5.  Randomised trial of glutamine and selenium supplemented parenteral nutrition for critically ill patients. Protocol Version 9, 19 February 2007 known as SIGNET (Scottish Intensive care Glutamine or seleNium Evaluative Trial).

Authors:  Peter J D Andrews; Alison Avenell; David W Noble; Marion K Campbell; Claire G Battison; Bernard L Croal; William G Simpson; John Norrie; Luke D Vale; Jonathon Cook; Robyn de Verteuil; Anne C Milne
Journal:  Trials       Date:  2007-09-20       Impact factor: 2.279

6.  Selenium status and cardiovascular risk profile in healthy adult Saudi males.

Authors:  Eman M Alissa; Waqar H Ahmed; Nabeel Al-ama; Gordon A A Ferns
Journal:  Molecules       Date:  2008-12-31       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.